CIP
SCLN

Convergence Investment Partners’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Convergence Investment Partners’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-76,895
Closed -$788K – 408
2016
Q3 		$788K Buy
+76,895
New +$788K 0.12% 257